Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center

Table 1

Patient characteristics.

	Group 1	Group 2	𝑃 value
Males/females	29/23 (55.8%/44.2%)	61/48 (55.9%/44.0%)	1.00
Age at diagnosis (years)	62.0 (40–84)	62.0 (39–90)	0.54
Height, mean (cm)	173.48 (156–189)	172.40 (153–196)	0.538
Weight, mean (kg)	68.31 (40–100)	75.89 (42–123)	0.018
Duration of symptoms prior to diagnosis (months)	11.5 months (1–80)	6.0 months (0–168)	0.02
Carcinoid tumour symptoms at referral:
(i) abdominal pain	34.7% (17/49)	25.2% (27/107)	0.25
(ii) diarrhea	55.1% (27/49)	39.3% (42/107)	0.82
(iii) flushing	30.6% (15/49)	33.6% (36/107)	0.85
(iv) bronchial obstruction	2.0% (1/49)	0.9% (1/107)	0.50